Mohammad Yaghoobi, MD, MSc(Epi), AFS, FRCPC
|Dr Yaghoobi, joined the Division of Gastroenterology and Hepatology effective July 1, 2013 as a Clinical Instructor. He earned his Medical Degree from the University of Tehran in 2002 followed by an AFS degree from the University of Paris in France in 2004. He then completed simultaneous master’s degrees in health research methodology and research and clinical fellowship in gastroenterology at McMaster University Department of Clinical Epidemiology and Biostatistics, Division of Gastroenterology and Intestinal Diseases Research Program in 2007. He did his internal medicine residency at University of Toronto from 2008 to 2011 and Gastroenterology and Hepatology at McGill University from 2011 to 2013.|
Dr Yaghoobi is board-certified in both Internal Medicine and Gastroenterology and Hepatology by both American Board of Internal Medicine and Royal College of Physicians and Surgeons of Canada. He is a member of several organizations, including, the American Gastroenterological Association; American College of Gastroenterology; and Canadian Association of Gastroenterology. Dr Yaghoobi’s clinical interests include advanced endoscopy, ERCP, endoscopic ultrasound and minimally invasive endoscopic surgeries. As part of his current faculty position at MUSC, he is involved in training medical students, residents and future gastroenterologists.
Dr. Yaghoobi is currently the Editor-in-Chief of the American College of Gastroenterology Case Reports Journal, an Editor of the Cochrane Upper Gastrointestinal and Pancreatic Diseases (UGPD) Review Group and a member of the Publication Committee of the American College of Gastroenterology. He has published more than 50 papers and abstracts including several meta-analyses specifically on digestive disease. Dr Yaghoobi's area of expertise is evidence-based gastroenterology including meta-analysis and systematic reviews in gastrointestinal diseases, advanced endoscopy and endoscopic ultrasound as well as upper gastrointestinal malignant and pre-malignant pathologies.